Drug:
Reaction: DEATH
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26550821 |
CA |
59 | 1 |
Death, Off label use, |
||||
FARICIMAB, |
||||
| 202 | 26550824 |
US |
75 | 2 |
Death, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 203 | 26550825 |
US |
93 | 2 |
Death, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 204 | 26550842 |
US |
1 | |
Death, Lung disorder, |
||||
PREDNISONE, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, |
||||
| 205 | 26550892 |
US |
70 | 1 |
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 206 | 26550907 |
US |
86 | |
Death, Off label use, |
||||
NIVOLUMAB, |
||||
| 207 | 26550918 |
EU |
2 | |
Death, Myocarditis-myositis-myasthenia gravis overlap syndrome, |
||||
PEMBROLIZUMAB, |
||||
| 208 | 26550958 |
AR |
2 | |
Death, |
||||
DURVALUMAB, |
||||
| 209 | 26551062 |
BR |
65 | 1 |
Death, Thrombosis, Colorectal cancer metastatic, Complication associated with device, Dry skin, Muscle injury, Rash, Acne, Stomatitis, Throat clearing, Skin lesion, Off label use, |
||||
PANITUMUMAB, PANITUMUMAB, PANITUMUMAB, PANITUMUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, LOSARTAN, MORPHINE SULFATE, PREGABALIN, CAPECITABINE, |
||||
| 210 | 26551074 |
US |
77 | 1 |
Death, |
||||
EDARAVONE, EDARAVONE, |
||||
| 211 | 26551076 |
US |
57 | 1 |
Death, |
||||
EDARAVONE, EDARAVONE, |
||||
| 212 | 26551092 |
US |
93 | 2 |
Death, |
||||
DRONEDARONE, |
||||
| 213 | 26551120 |
CA |
80 | 2 |
Death, Product lot number issue, |
||||
RISANKIZUMAB-RZAA, |
||||
| 214 | 26551168 |
JP |
74 | 1 |
Death, |
||||
GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, |
||||
| 215 | 26551197 |
US |
86 | 1 |
Death, Unresponsive to stimuli, Fall, Chills, Inappropriate schedule of product administration, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CARVEDILOL, DUTASTERIDE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, GABAPENTIN, GLIPIZIDE, GLIPIZIDE-TABLETS, LATANOPROST, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PIOGLITAZONE, |
||||
| 216 | 26551246 |
US |
73 | 1 |
Death, |
||||
OLAPARIB, |
||||
| 217 | 26551272 |
US |
81 | 2 |
Death, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 218 | 26551348 |
EU |
2 | |
Death, |
||||
POMALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ISATUXIMAB, |
||||
| 219 | 26551400 |
US |
1 | |
Death, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 220 | 26551413 |
US |
1 | |
Death, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 221 | 26551428 |
US |
2 | |
Death, |
||||
NICOTINE TRANSDERMAL SYSTEM PATCH, |
||||
| 222 | 26551430 |
IN |
78 | 2 |
Death, Drug ineffective, |
||||
OSIMERTINIB, |
||||
| 223 | 26551445 |
US |
1 | |
Death, |
||||
LEVODOPA, |
||||
| 224 | 26551451 |
AR |
2 | |
Death, |
||||
OSIMERTINIB, |
||||
| 225 | 26551513 |
US |
80 | 1 |
Death, |
||||
THALIDOMIDE, |
||||
| 226 | 26551594 |
MX |
||
Death, |
||||
MACITENTAN, |
||||
| 227 | 26551611 |
CA |
46 | 1 |
Death, |
||||
UPADACITINIB, |
||||
| 228 | 26551619 |
US |
82 | 1 |
Death, |
||||
BRENSOCATIB, ALBUTEROL SULFATE, ALBUTEROL, ALLOPURINOL, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, DAPAGLIFLOZIN, PIRTOBRUTINIB, POTASSIUM ACETATE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, VENETOCLAX, ACYCLOVIR, |
||||
| 229 | 26551627 |
CO |
71 | 2 |
Death, |
||||
DENOSUMAB, |
||||
| 230 | 26551664 |
TH |
73 | 2 |
Death, Hospitalisation, |
||||
DENOSUMAB, DENOSUMAB, |
||||
| 231 | 26551688 |
ZA |
66 | 1 |
Death, Unevaluable event, |
||||
DARBEPOETIN ALFA, |
||||
| 232 | 26551723 |
US |
||
Death, |
||||
FENTANYL, |
||||
| 233 | 26551735 |
US |
1 | |
Death, Gastric cancer, |
||||
MORPHINE, FENTANYL, |
||||
| 234 | 26551778 |
AU |
||
Death, |
||||
DENOSUMAB, |
||||
| 235 | 26551855 |
US |
1 | |
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 236 | 26551886 |
US |
84 | 2 |
Death, |
||||
VORTIOXETINE, |
||||
| 237 | 26551908 |
1 | ||
Death, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 238 | 26551996 |
CN |
59 | 1 |
Death, |
||||
NILOTINIB, |
||||
| 239 | 26552029 |
US |
2 | |
Death, |
||||
INCLISIRAN, |
||||
| 240 | 26552154 |
73 | ||
Death, Illness, Infection, Inappropriate schedule of product administration, Off label use, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 241 | 26552191 |
US |
91 | 2 |
Death, Fall, |
||||
RIOCIGUAT, |
||||
| 242 | 26552237 |
CA |
1 | |
Death, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 243 | 26552245 |
GB |
70 | 1 |
Procedural anxiety, Abdominal discomfort, Death, Dyspnoea, |
||||
| 244 | 26552268 |
US |
82 | |
Death, |
||||
INCOBOTULINUMTOXINA, |
||||
| 245 | 26552329 |
US |
2 | |
Death, |
||||
DENOSUMAB, |
||||
| 246 | 26552331 |
GB |
85 | 2 |
Death, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 247 | 26552376 |
US |
82 | |
Death, |
||||
RUXOLITINIB, |
||||
| 248 | 26552397 |
94 | 2 | |
Death, |
||||
DENOSUMAB, |
||||
| 249 | 26552410 |
US |
1 | |
Death, Gastric cancer, |
||||
FENTANYL, MORPHINE, |
||||
| 250 | 26552413 |
CA |
1 | |
Death, |
||||
VEDOLIZUMAB, PREDNISONE, |
||||
| 251 | 26552547 |
US |
89 | 2 |
Death, |
||||
BREXPIPRAZOLE, |
||||
| 252 | 26552548 |
US |
1 | |
Death, |
||||
EPOETIN ALFA, |
||||
| 253 | 26552569 |
US |
82 | |
Death, |
||||
NIACIN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, |
||||
| 254 | 26552570 |
CA |
80 | 1 |
Death, Hypertension, Hyperphosphataemia, Pulmonary embolism, Iron deficiency, Hypophosphataemia, Chronic obstructive pulmonary disease, |
||||
FLUTICASONE PROPIONATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, DEXPANTHENOL, DOBUTAMINE, GABAPENTIN, GABAPENTIN, GABAPENTIN, HEPARIN SODIUM, HEPARIN SODIUM, HEPARIN SODIUM, HEPARIN SODIUM, HEPARIN SODIUM, HEPARIN SODIUM, HEPARIN SODIUM, HEPARIN SODIUM, HEPARIN SODIUM, HEPARIN SODIUM, HEPARIN SODIUM, HEPARIN SODIUM, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, METRONIDAZOLE, METRONIDAZOLE TOPICAL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, AMIODARONE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, VASOPRESSIN, VASOPRESSIN, VASOPRESSIN, VASOPRESSIN, VASOPRESSIN, VITAMIN C, PHYTONADIONE, PHYTONADIONE, PHYTONADIONE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, LANSOPRAZOLE, LANSOPRAZOLE, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, |
||||
| 255 | 26552610 |
US |
83 | 1 |
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 256 | 26552613 |
US |
2 | |
Death, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 257 | 26552614 |
US |
1 | |
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 258 | 26552626 |
US |
1 | |
Death, |
||||
BREXPIPRAZOLE, |
||||
| 259 | 26552671 |
63 | 1 | |
Death, |
||||
RITUXIMAB-ABBS, |
||||
| 260 | 26552700 |
US |
64 | |
Death, |
||||
| 261 | 26552811 |
72 | 1 | |
Death, |
||||
DUPILUMAB, LORAZEPAM, BUPROPION HYDROCHLORIDE, ALBUTEROL SULFATE, CITALOPRAM, TIOTROPIUM BROMIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, PREDNISONE, |
||||
| 262 | 26552812 |
60 | 2 | |
Death, |
||||
LOMUSTINE, |
||||
| 263 | 26552926 |
EU |
2 | |
Death, Off label use, |
||||
OSIMERTINIB, |
||||
| 264 | 26552948 |
US |
75 | |
Death, |
||||
| 265 | 26552967 |
CO |
74 | 2 |
Death, Infection, Pyrexia, Acute myeloid leukaemia, Transfusion, |
||||
VENETOCLAX, |
||||
| 266 | 26553063 |
EU |
2 | |
Death, |
||||
PANITUMUMAB, |
||||
| 267 | 26553137 |
EU |
2 | |
Death, Off label use, |
||||
OSIMERTINIB, |
||||
| 268 | 26553211 |
84 | ||
Death, |
||||
| 269 | 26553235 |
US |
72 | |
Death, |
||||
| 270 | 26553258 |
US |
38 | |
Death, Off label use, |
||||
| 271 | 26553299 |
US |
39 | 1 |
Death, |
||||
RISANKIZUMAB-RZAA, |
||||
| 272 | 26553300 |
US |
1 | |
Death, |
||||
IBRUTINIB, |
||||
| 273 | 26553364 |
US |
||
Death, |
||||
MORPHINE, FENTANYL, |
||||
| 274 | 26553371 |
US |
1 | |
Death, |
||||
DAPAGLIFLOZIN, |
||||
| 275 | 26553392 |
US |
||
Death, |
||||
| 276 | 26553431 |
GB |
2 | |
Death, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 277 | 26553626 |
CA |
1 | |
Death, |
||||
SILDENAFIL CITRATE, |
||||
| 278 | 26553634 |
US |
67 | 1 |
Death, Pulmonary oedema, Intentional product use issue, |
||||
BOSUTINIB, BOSUTINIB, BOSUTINIB, BOSUTINIB, BOSUTINIB, BOSUTINIB, BOSUTINIB, |
||||
| 279 | 26553668 |
EU |
43 | 2 |
Death, |
||||
MORPHINE SULFATE, TRAMADOL HYDROCHLORIDE, |
||||
| 280 | 26553671 |
EU |
18 | 2 |
Death, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 281 | 26553697 |
1 | ||
Death, |
||||
LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 282 | 26553713 |
CA |
72 | 1 |
Death, |
||||
CLOZAPINE, |
||||
| 283 | 26553741 |
CA |
2 | |
Death, |
||||
SILDENAFIL CITRATE, MACITENTAN, |
||||
| 284 | 26553873 |
CA |
80 | 2 |
Death, Renal impairment, Renal impairment, Product dose omission issue, Wheelchair user, General physical health deterioration, Therapy interrupted, |
||||
| 285 | 26553892 |
US |
71 | 1 |
Death, |
||||
OSIMERTINIB, |
||||
| 286 | 26553895 |
HN |
1 | |
Death, |
||||
| 287 | 26553906 |
US |
68 | |
Death, |
||||
VUTRISIRAN, |
||||
| 288 | 26553918 |
EU |
77 | 2 |
Death, |
||||
| 289 | 26553950 |
EU |
82 | 1 |
Death, |
||||
CLOPIDOGREL, BISOPROLOL FUMARATE, BORTEZOMIB, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, PANTOPRAZOLE, VALACYCLOVIR HYDROCHLORIDE, CHOLESTYRAMINE, FERROUS SULFATE, |
||||
| 290 | 26553984 |
US |
86 | |
Death, |
||||
| 291 | 26554006 |
MX |
82 | 1 |
Death, |
||||
RIVASTIGMINE, |
||||
| 292 | 26554028 |
MX |
85 | 1 |
Death, |
||||
RIVASTIGMINE, |
||||
| 293 | 26554163 |
AU |
2 | |
Death, |
||||
CEDAZURIDINE AND DECITABINE, |
||||
| 294 | 26554197 |
US |
||
Death, Paralysis, |
||||
VUTRISIRAN, |
||||
| 295 | 26554217 |
US |
6 | 2 |
Death, Dyspnoea, Neoplasm progression, Acute respiratory failure, Metastases to meninges, Dysphagia, Seizure, |
||||
DORDAVIPRONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FAMOTIDINE, SIMVASTATIN, LEVETIRACETAM, LEVETIRACETAM, LORAZEPAM, DIPHENHYDRAMINE HYDROCHLORIDE, SENNOSIDES, SENNA LEAF, SENNA, GLYCOPYRROLATE, MORPHINE SULFATE, DEXMEDETOMIDINE HYDROCHLORIDE, SIMVASTATIN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 296 | 26554226 |
US |
61 | 1 |
Death, |
||||
FRUQUINTINIB, ESOMEPRAZOLE MAGNESIUM, OLMESARTAN MEDOXOMIL, AMLODIPINE BESYLATE, |
||||
| 297 | 26554228 |
US |
91 | |
Death, |
||||
VUTRISIRAN, |
||||
| 298 | 26554250 |
76 | 1 | |
Death, |
||||
RISANKIZUMAB-RZAA, |
||||
| 299 | 26554270 |
US |
||
Death, |
||||
VUTRISIRAN, |
||||
| 300 | 26554299 |
GB |
||
Death, Off label use, |
||||
ELAFIBRANOR, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28